Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG37130

GORAB Knockout Hela Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Uterus (cervix)

  • Disease:

    Adenocarcinoma

The GORAB Knockout HeLa Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal population of HeLa cells with targeted disruption of GORAB. This knockout model enables loss-of-function studies of the GORAB golgin, a trans-Golgi network protein that interacts with RAB6A and SCYL1 to regulate retrograde trafficking and primary cilium assembly. Applications include Golgi architecture analysis, secretion assays, and ciliogenesis research in a cervical adenocarcinoma background. The polyclonal format reduces clonal bias, providing a robust system for investigating GORAB-dependent mechanisms in cancer cell biology and disease modeling.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HeLa

    Sex of Donor

    Female

    Age

    31 years

    Gene Name

    GORAB

    Gene Identifier

    NCBI Gene ID 92344

    Morphology

    Epithelial-like

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    MEM (with NEAA)

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The GORAB Knockout HeLa Polyclonal Cells consist of a CRISPR/Cas9-mediated polyclonal knockout population of HeLa cells, designed for loss-of-function studies of the GORAB gene. This heterogeneous pool represents multiple editing events, minimizing clonal effects and providing a robust experimental system. Knockout efficiency can be assessed by western blotting and Sanger sequencing, and the cells are supplied ready-to-use for downstream applications including imaging, biochemical, and functional assays.

The parental HeLa cell line is a human cervical epithelial adenocarcinoma model positive for HPV-18, extensively utilized in cancer biology research. Its epithelial origin and transformed state make it suitable for investigating Golgi organization and secretion in a malignancy-relevant context. HeLa cells also support standard cell biology techniques such as immunofluorescence microscopy and secretion assays, and are compatible with migration and invasion studies.

GORAB is a trans-Golgi network golgin that interacts with RAB6A and SCYL1 to coordinate retrograde COPI vesicle trafficking and Golgi ribbon integrity. Its membrane recruitment depends on ARF GTPases, placing it downstream of RAB6 activation. GORAB disruption leads to Golgi fragmentation, defective primary cilium assembly, and impaired secretion of matrix proteins, underscoring its role in linking trafficking to ciliogenesis and tissue organization.

In the HeLa background, GORAB knockout provides a model to study how Golgi dysfunction intersects with HPV-18-driven oncogenesis. Researchers can investigate impacts on secretory pathways, cell migration, and matrix remodeling, which are hallmarks of cervical carcinoma progression. The system also allows in vitro exploration of geroderma osteodysplasticum, a GORAB-linked skeletal dysplasia, even in a non-osteogenic lineage, by dissecting ciliary and trafficking defects.

Research applications include immunofluorescence for Golgi markers (GM130, TGN46), co-immunoprecipitation with RAB6, luciferase-based secretion assays, and serum-starvation-induced ciliogenesis assays. The cells are also suited for cell migration and invasion assays, facilitating correlations between Golgi integrity and cancer cell behavior. For further details, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)